DDD Stock Recent News

NEW YORK, NY / ACCESS Newswire / April 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of 3D Systems Corporation ("3D Systems" or the "Company") (NYSE:DDD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

NEW YORK CITY, NY / ACCESS Newswire / April 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of 3D Systems Corporation ("3D Systems" or the "Company") (NYSE:DDD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

NEW YORK , April 14, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  3D Systems Corporation ("3D Systems" or the "Company") (NYSE: DDD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

NEW YORK CITY, NY / ACCESS Newswire / April 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of 3D Systems Corporation ("3D Systems" or the "Company") (NYSE:DDD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

NEW YORK , April 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  3D Systems Corporation ("3D Systems" or the "Company") (NYSE: DDD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

ROCK HILL, S.C., April 08, 2025 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE: DDD) announced that in collaboration with the University Hospital Basel (Switzerland) the Company's unique point-of-care additive manufacturing solution has been used to design and produce the world's first Medical Device Regulation (MDR)-compliant 3D-printed PEEK facial implant. Prof. Florian Thieringer and Dr. Neha Sharma, together with their team of biomedical engineers, successfully designed and manufactured a custom device to address a patient's unique need using 3D Systems technology and product manufacturing expertise. They used this implant as part of a successful surgery completed at the hospital on March 18, 2025. Production of the first MDR-compliant facial implant was completed using VESTAKEEP® i4 3DF PEEK by Evonik on 3D Systems' EXT 220 MED. The cleanroom-based architecture of the printer and simplified post-processing workflows enable the efficient production of patient-specific medical device

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  3D Systems Corporation (“3D Systems” or the “Company”) (NYSE: DDD).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

ROCK HILL, S.C., April 07, 2025 (GLOBE NEWSWIRE) -- 3D Systems (NYSE: DDD) is unveiling several new solutions designed to change the way industries innovate. At RAPID+TCT 2025, the Company will showcase its Figure 4® 135 3D printer and Figure 4 Tough 75C FR Black material that form the foundation of its cost-effective additive manufacturing solution for precision, high mix, low volume applications such as motorsports components, furniture hardware, and electrical connectors. Additionally, 3D Systems will debut its first-to-market new module for its EXT Titan Pellet printers which delivers greatly improved process efficiency for a breadth of applications that require machining during post-processing. Furthermore, bolstering its pioneering work in investment casting, 3D Systems is announcing availability of the QuickCast® Diamond build style, available in 3D Systems' 3D Sprint® software, to be used with its PSLA 270 projector-based technology, accelerating time to part-in-hand. The Co

NEW YORK CITY, NY / ACCESS Newswire / April 6, 2025 / Pomerantz LLP is investigating claims on behalf of investors of 3D Systems Corporation ("3D Systems" or the "Company") (NYSE:DDD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

NEW YORK CITY, NY / ACCESS Newswire / April 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of 3D Systems Corporation ("3D Systems" or the "Company") (NYSE:DDD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.